Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Sean Kim is an analyst at JonesTrading. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/02/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
02/13/2024 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Sean Kim29% | — | Downgrade | Buy → Hold | Get Alert |
11/09/2023 | DRRX | Buy Now | Durect | $0.69 | — | Sean Kim29% | — | Downgrade | Buy → Hold | Get Alert |
11/08/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $15.30 | — | Sean Kim29% | — | Downgrade | Buy → Hold | Get Alert |
06/14/2023 | CLSD | Buy Now | Clearside Biomedical | $0.90 | 563.06% | Sean Kim29% | → $6 | Initiates | → Buy | Get Alert |
06/14/2023 | OVID | Buy Now | Ovid Therapeutics | $0.32 | 1754.14% | Sean Kim29% | → $6 | Initiates | → Buy | Get Alert |
06/14/2023 | EYPT | Buy Now | EyePoint Pharmaceuticals | $7.30 | 256.16% | Sean Kim29% | → $26 | Initiates | → Buy | Get Alert |
03/14/2023 | TRVI | Buy Now | Trevi Therapeutics | $7.20 | -2.78% | Sean Kim29% | → $7 | Initiates | → Buy | Get Alert |
03/14/2023 | DRRX | Buy Now | Durect | $0.69 | 5272.44% | Sean Kim29% | → $37 | Initiates | → Buy | Get Alert |
01/20/2023 | CNCE | Buy Now | Concert Pharma | — | — | Sean Kim29% | — | Downgrade | Buy → Hold | Get Alert |
09/22/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $15.30 | 252.94% | Sean Kim29% | → $54 | Assumes | → Buy | Get Alert |
08/25/2022 | STSA | Buy Now | Satsuma Pharma | — | — | Sean Kim29% | → $14 | Initiates | → Buy | Get Alert |
08/25/2022 | IMPL | Buy Now | Impel Pharmaceuticals | — | — | Sean Kim29% | → $26 | Initiates | → Buy | Get Alert |
08/25/2022 | CNCE | Buy Now | Concert Pharma | — | — | Sean Kim29% | → $17 | Initiates | → Buy | Get Alert |